Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

FLOATGLASS INDIA

Article Abstract:

Floatglass India has as its promoters, Asahi of Japan and ACC, Telco and Tata Exports. Asahi Glass holds 49 percent stake in FloatGlass while the three Tata group companies together hold a stake of 26 percent. The company manufactures floatglass used in construction, automobiles and furniture. It is currently incurring losses due to oversupply and recession in the user industry. Its exports are set to improve as Floatglass is poised to capture markets once monopolised by the South East Asian countries. Recently Asahi contributed Rs20 crore to the company through preference shares. The company's scrip is ruling at Rs11.30 now. (uh) ------------------------------------------------------------ Financial Highlights of Floatglass India (Rs in crore) ------------------------------------------------------------ Particulars Six months ended Six months ended September 1997 September 1996 ------------------------------------------------------------ Sales 63.52 69.73 ------------------------------------------------------------ Gross Loss 14.94 34.35 ------------------------------------------------------------ Depreciation 14.19 13.94 ------------------------------------------------------------ Net Loss 29.13 48.29 ------------------------------------------------------------ Equity 78.02 78.02 ------------------------------------------------------------ Earnings per share (3.73) (6.19) ------------------------------------------------------------

Comment:

Manufactures floatglass used in construction, automobiles & furniture, company profile

Publisher: Boom Trading & Investments
Publication Name: Dalal Street Journal
Subject: Business, international
ISSN:
Year: 1998
Flat Glass Manufacturing, Float Glass, Floatglass (India)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


NOVARTIS INDIA: WORLD LEADER

Article Abstract:

Novartis India (NI) is a subsidiary of Novartis of Switzerland. Sandoz and Hindustan Ciba Geigy were merged to form NI. It has 2 divisions - agriculture and pharmaceuticals. The agriculture division contributed 67 percent to the total sales of Rs607 crore in 1996-97. It plans to launch several over-the-counter products which are likely to fetch for it Rs325 crore by December 1998. --------------------------------------------------------- Financial performance of Novartis India (Rs in crore) --------------------------------------------------------- Particulars 6 months ended September Year ended 1997 1996 March 1997 --------------------------------------------------------- Net sales 334.80 304.40 607.21 --------------------------------------------------------- Other income 6.80 14.10 25.40 --------------------------------------------------------- Interest 8.10 8.70 17.20 --------------------------------------------------------- Operating profit 33.20 30.50 40.00 --------------------------------------------------------- Depreciation 6.60 8.30 12.80 --------------------------------------------------------- Net profit 15.40 17.60 18.61 --------------------------------------------------------- Equity 31.86 26.56 31.86 --------------------------------------------------------- EPS (Rs) 9.67 13.25 5.84 --------------------------------------------------------- Its scrip is traded at Rs360 at 38 times its earning per share. (rk)

Comment:

Plans to launch several over-the-counter products which are likely to fetch for it Rs325 crore by 12/98

Publisher: Boom Trading & Investments
Publication Name: Dalal Street Journal
Subject: Business, international
ISSN:
Year: 1998
Pharmaceutical Preparation Manufacturing, Proprietary Preparations, Proprietary drugs, Novartis India Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


GAMMONS INDIA: IMPROVING PERFORMANCE

Article Abstract:

Gammon India Ltd (GIL) is engaged in the manufacture of reinforced concrete, construction of bridges, cooling towers, tunnels and dams. It plans to enter the infrastructure segment with an investment of Rs40 crore. It plans to enter into a 50:50 alliance for its cooling tower business. (rk) ------------------------------------------------------------ Financial results of Gammon India Ltd ------------------------------------------------------------ Particulars March 1998 March 1997 (Rs in crore) ------------------------------------------------------------ Gross sales 215.66 180.08 ------------------------------------------------------------ Gross profit 21.53 15.90 ------------------------------------------------------------ Depreciation 3.91 3.63 ------------------------------------------------------------ Interest 7.47 7.02 ------------------------------------------------------------ Tax 3.15 0.70 ------------------------------------------------------------ Net profit 7.01 4.55 ------------------------------------------------------------ Equity 2.16 2.16 ------------------------------------------------------------ EPS (Rs) 31.86 20.68 ------------------------------------------------------------ Dividend (%) 35.00 35.00 ------------------------------------------------------------ Book value (Rs) 179.64 151.05 ------------------------------------------------------------

Comment:

Is engaged in manufacture of reinforced concrete, construction of bridges, cooling towers, tunnels and dams

Publisher: Boom Trading & Investments
Publication Name: Dalal Street Journal
Subject: Business, international
ISSN:
Year: 1998
Bridge and Tunnel Construction, Bridge & Tunnel Construction, Tunnel construction, Bridge construction, Gammon India Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: India, Article
Similar abstracts:
  • Abstracts: CAPRIHANS INDIA CONTAINER CORPORATION OF INDIA PEERLESS ABASAN FINANCE
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.